All Stories

  1. Society of Pain And Palliative Care Pharmacists (SPPCP) Position Statement on the Proposed Change of Naloxone to Over-the-Counter (OTC) Status

    Article • Journal of Pain & Palliative Care Pharmacotherapy, April 2019, Taylor & Francis

    Dr Jeffrey Fudin

  2. Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids

    Article • Journal of Pain Research, October 2018, Dove Medical Press

    Lisa Dragic, Dr Jeffrey Fudin, Dr Michael E. Schatman

  3. The CDC Opioid Guideline: Proponent Interpretation Has Led to Misinformation

    Article • Clinical Pharmacology & Therapeutics, April 2018, Wiley

    Dr Jeffrey Fudin

  4. Safety concerns with the Centers for Disease Control opioid calculator

    Article • Journal of Pain Research, December 2017, Dove Medical Press

    Dr Jeffrey Fudin, Dr. Erica L. Wegrzyn, Dr Michael E. Schatman

  5. Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes

    Article • Journal of Pain Research, December 2017, Dove Medical Press

    Dr Michael E. Schatman, Dr. Erica L. Wegrzyn, Lisa Dragic, Dr Jeffrey Fudin

  6. Rational dosing of gabapentin and pregabalin in chronic kidney disease

    Article • Journal of Pain Research, January 2017, Dove Medical Press

    Dr Jeffrey Fudin

  7. Opioids and Related Medications

    Article • January 2017, Springer Science + Business Media

    Dr Jeffrey Fudin

  8. Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease

    Article • Journal of Pain Research, December 2016, Dove Medical Press

    Dr. Erica L. Wegrzyn, Jeffrey Bettinger, Dr Jeffrey Fudin

  9. Can we not work together to help family practitioners become more effective pain managers?

    Article • Journal of Pain Research, October 2016, Dove Medical Press

    Dr Jeffrey Fudin, Dr Michael E. Schatman

  10. OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form

    Article • Journal of Pain Research, September 2016, Dove Medical Press

    Dr Jeffrey Fudin, Dr. Erica L. Wegrzyn

  11. Levorphanol use: past, present and future

    Article • Postgraduate Medicine, December 2015, Taylor & Francis

    Dr Jeffrey Fudin

  12. Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing

    Article • Clinical Journal of Pain, December 2015, Wolters Kluwer Health

    Dr Jeffrey Fudin

  13. Is levorphanol a better option than methadone?

    Article • Pain Medicine, September 2015, Oxford University Press (OUP)

    Dr Jeffrey Fudin

  14. Variability in Opioid Equivalence Calculations

    Article • Pain Medicine, September 2015, Oxford University Press (OUP)

    Dr Jeffrey Fudin

  15. Equation that predicts methadone removal during dialysis

    Article • Journal of Pain Research, July 2015, Dove Medical Press

    Mr Jeffrey James Bettinger, Dr Jeffrey Fudin

  16. Combined Fentanyl and Methadone Induced Serotonin Syndrome is Called Into Question

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, June 2015, Wiley

    Dr Jeffrey Fudin

  17. CYP2D6 Phenotype-Specific Codeine Population Pharmacokinetics

    Article • Journal of Pain & Palliative Care Pharmacotherapy, January 2015, Taylor & Francis

    Dr Jeffrey Fudin

  18. Potential Cost-Shifting and Hidden Costs and Risks in the Economic Analysis of Opioid Abuse-Deterrent Formulations

    Article • Pain Medicine, September 2014, Oxford University Press (OUP)

    Dr Jeffrey Fudin

  19. Oxycodone recycling: A novel hypothesis of opioid tolerance development in humans

    Article • Medical Hypotheses, September 2014, Elsevier

    Dr Jeffrey Fudin

  20. The damage done by the war on opioids: the pendulum has swung too far

    Article • Journal of Pain Research, May 2014, Taylor & Francis

    Dr Michael E. Schatman, Dr Jeffrey Fudin

  21. Personalized Oxycodone Dosing: Using Pharmacogenetic Testing and Clinical Pharmacokinetics to Reduce Toxicity Risk and Increase Effectiveness

    Article • Pain Medicine, May 2014, Oxford University Press (OUP)

    Dr Jeffrey Fudin, Dr Oscar Linares

  22. Personalized Oxycodone Dosing: Using Pharmacogenetic Testing and Clinical Pharmacokinetics to Reduce Toxicity Risk and Increase Effectiveness

    Article • Pain Medicine, May 2014, Oxford University Press (OUP)

    Dr Jeffrey Fudin

  23. Opioid Prescribing Levels Off, but Is Less Really More?

    Article • Pain Medicine, January 2014, Oxford University Press (OUP)

    Dr Jeffrey Fudin

  24. What's New in NSAID Pharmacotherapy: Oral Agents to Injectables

    Article • Pain Medicine, December 2013, Oxford University Press (OUP)

    Dr Jeffrey Fudin

  25. Medication Pain Management in the Elderly: Unique and Underutilized Analgesic Treatment Options

    Article • Clinical Therapeutics, November 2013, Elsevier

    Dr Jeffrey Fudin

  26. Potential P-glycoprotein Pharmacokinetic Interaction of Telaprevir With Morphine or Methadone

    Article • Journal of Pain & Palliative Care Pharmacotherapy, July 2013, Taylor & Francis

    Dr Jeffrey Fudin

  27. Rifampin Reduces Oral Morphine Absorption: A Case of Transdermal Buprenorphine Selection Based on Morphine Pharmacokinetics

    Article • Journal of Pain & Palliative Care Pharmacotherapy, December 2012, Taylor & Francis

    Dr Jeffrey Fudin

  28. A New Pattern of Buprenorphine Misuse May Complicate Perioperative Pain Control

    Article • Anesthesia & Analgesia, June 2009, Wolters Kluwer Health

    Dr Jeffrey Fudin

  29. Blowing the whistle: A pharmacist’s vexing experience unraveled

    Article • American Journal of Health-System Pharmacy, November 2006, American Society of Health System Pharmacists

    Dr Jeffrey Fudin

  30. Chronic Pain Management with Opioids in Patients with Past or Current Substance Abuse Problems

    Article • Journal of Pharmacy Practice, August 2003, SAGE Publications

    Dr Jeffrey Fudin

  31. Letters to the editor

    Article • American Journal of Hospice and Palliative Medicine®, November 2001, SAGE Publications

    Dr Jeffrey Fudin

  32. Enteral patient-controlled analgesia

    Article • The Lancet, October 1994, Elsevier

    Dr Jeffrey Fudin

  33. REVIEWING THE “BIG THREE” INJECTION ROUTES

    Article • Nursing, February 1992, Wolters Kluwer Health

    Dr Jeffrey Fudin